Author: Bozkurt, Hüseyin S; Quigley, Eamonn MM
Title: The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis Cord-id: 74e5ctt5 Document date: 2020_10_25
ID: 74e5ctt5
Snippet: COVID-19 is a viral pandemic that primarily manifests with respiratory distress but may also lead to symptoms and signs associated with the gastrointestinal tract. It is characteristically associated with a hyper-immune response, also referred to as a ‘cytokine storm’. Probiotics are living microorganisms that have been shown to have positive effects on immune response in man with some bacteria; some strains of Bifidobacteria, for example, possess especially potent immune modulating effects.
Document: COVID-19 is a viral pandemic that primarily manifests with respiratory distress but may also lead to symptoms and signs associated with the gastrointestinal tract. It is characteristically associated with a hyper-immune response, also referred to as a ‘cytokine storm’. Probiotics are living microorganisms that have been shown to have positive effects on immune response in man with some bacteria; some strains of Bifidobacteria, for example, possess especially potent immune modulating effects. These bacteria have the potential to ameliorate the ‘cytokine storm’ through a differential effect on pro- and anti-inflammatory cytokines. In the management of COVID-19 and other coronovirus-mediated illnesses, probiotic bacteria also have the potential to enhance vaccine efficacy.
Search related documents:
Co phrase search for related documents- abdominal pain and acute respiratory infection illness: 1, 2, 3
- abdominal pain and admission rate: 1, 2, 3, 4, 5
- abdominal pain and lung injury: 1, 2, 3, 4, 5
- acute respiratory infection and adaptive immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute respiratory infection and admission rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- acute respiratory infection and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute respiratory infection illness and lung injury: 1
- adaptive immune system and lung injury: 1, 2, 3
- admission rate and lung injury: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date